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Original Article 
INTRODUCTION 
Pleural effusions represent a very common diagnostic 
task to the physician. A correct diagnosis of the underly-
ing disease is essential to the rational management [1]. 
Normally the pleural space contains only a few millime-
tres of fluid. Accumulation of excessive amount of fluid 
is a frequent manifestation of many diseases of both 
thoracic and extra thoracic. Indeed pleural effusion must 
be regarded as a trivial event but as a sign of major dis-
order or disease [2]. 
The first diagnostic step is the identification of pleural 
effusions as either a transudate or exudates. This is use-
ful because it indicates the pathophysiological mecha-
nisms involved. Exudates are secondary to alteration of 
capillary permeability or lymphatic drainage. Transu-
dates are due to either alterations of hydrostatic and / or 
osmotic pressure in pleural capillaries or to a fluid pass-
ing from the peritoneal cavity via diaphragmatic defects. 
If an exudate is present further diagnostic procedures 
and tests are imperative for definitive diagnosis and 
specific therapy. On the other hand if the fluid is clearly 
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a transudate one need not worry about manoeuvres di-
rected at the pleura and need to treat only the congestive 
cardiac failure, nephrosis, cirrhosis or hypoproteinemia 
[3]. 
Over the years many criteria have been developed by 
various workers for separation of exudates and transu-
dates. 
Objective: To study the diagnostic value of Pleural 
fluid Cholesterol in differentiating transudative and exu-
dative pleural effusions. 
MATERIALS AND METHODS 
Study design: Cross sectional descriptive study 
Ethics approval: Study was approved by the institu-
tional ethics committee  
Place of research: BLDEU’S Shri B. M. Patil medical 
college hospital and research centre, Vijayapura. 
Study period: Period of study is from November 2016 
to July 2018. 
Inclusion Criteria: Data is collected from patients who 
are attending Medicine OPD and IPD. Age >18years, 
patients with definite clinical diagnosis and Pleural effu-
sion evidenced by radiological imaging. 
Exclusion criteria: Patients without definitive clinical 
diagnosis, and previously diagnosed or already on treat-
ment. 
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Sample size: Using expected incidence of exudates 
cases among pleural effusion as 69.4%,expected sensi-
tivity as 88%, expected specificity as 100% and desired 
precision as +/-10%.The minimum sample is 60.This 
sample size will give the precision of 10%for both sen-
sitivity and specificity. 
Formula used: N=z2 (1-p)/d2 
Z-value of z statistic at 5% level of significance, d-
margin of error, p-expected incidence rate 
Methodology: Complete history of the patient and clin-
ical signs and symptoms at presentation is collected and 
determined the side of effusion. Pleural fluid is aspirat-
ed and investigations like pleural fluid analsysis which 
includes pleural protein, pleural sugar, cell count, malig-
nancy and pleural cholesterol is estimated. Pleural fluid 
cholesterol criteria is applied to differentiate transudate 
and exudates (pleural cholesterol <45mg/dl transudate 
and >45mg/dl exudates) and compared with the stand-
ard Lights criteria (pleural fluid protein: serum pro-
tein>0.6) 
Statistical Analysis: Data will be analysed using 
mean+/-SD Chi square test for association, comparison 
of means using test, ANOVA for comparison between 
and within groups and diagrammatic presentation. 
RESULTS  
The present study was undertaken in 60 cases of Pleural 
Effusion over a period of 2 and half years from Novem-
ber 2016 to July 2018, the results of which are given 
below. 
Table 1. Age and sex distribution
 
Table 2. Distribution of symptoms in pleural effusion 
at presentation
 
AGE (years) 
Male Female 
p value 
N (%) N 
18-20 1 (2.6) 0(0) 
0.641 
21-30 5(13.2) 4(18.2) 
31-40 8(21.1) 7(31.8) 
41-50 12(31.6) 3(13.6) 
51-60 8(21.1) 5(22.7) 
>60 4(10.5) 3(13.6) 
Total 38 22 
Presenting symptoms 
Number of patients 
(%) 
Cough 50 (83.3) 
Fever 22(36.7) 
Chest pain 34(56.7) 
Dyspnoea 47(78.3) 
Swelling of limbs 10(16.7) 
Distension of abdomen 10(16.7) 
Facial puffiness 6(10) 
Loss of appetite 60 (100) 
Loss of weight 40(66.7) 
Table 3. Distribution of signs in pleural effusion at 
presentation
 
Table 4. Pleural effusion right and left side distribu-
tion 
 
Out of 60 patients, 36 had right sided effusion, 19 had 
left sided effusion,5 patients had bilateral pleural effu-
sion. 
Table 5. Appearance of pleural effusion
 
Colour of pleural effusion – 36 patients had amber col-
our, 18 patients had clear, 4 patients had haemorrhagic 
and straw colour in 2 patients. 
Table 6. Cytology of pleural effusion
 
Out of 60 patients, 3 patients had lymphocytes plus 
mesothelial cells, 42 patients had predominantly lym-
phocytes and 15 patients had predominantly neutrophils. 
Clinical signs N (%) 
Stony dullness 60 (100) 
Absent breath sound 50 (83.3) 
Decreased vf/vr 52 (86.7) 
Mediastinal shift 50 (83.3) 
Pleural rub 4 (6.6) 
Crepitations 5 (8.3) 
Side of effusion Number (%) 
Right 36 (60) 
Left 19 (31.7) 
Bilateral 5(8.3) 
Colour 
Total 
p value 
N % 
Amber 36 60.0 
0.864 
Clear 18 30.0 
Haemorrhagic 4 6.7 
Straw 2 3.3 
Total 60 100.0 
Cytology 
Total 
p value 
N 
Lymphocytes + Mesotheli-
al cells 
3 (5) 
0.476 
Predominantly lympho-
cytes 
42 (70) 
Predominantly neutrophils 15 (25) 
Total 60 
Int. j. clin. biomed. res. 2019;5(1):5-8. 
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Table 7. Distribution of pleural protein
 
The above table shows the values of pleural protein. 6 
patients had pleural protein values ranging from 1-2 
gram/dl, 16 patients of pleural protein ranging from 2-4 
gram/dl, 34 patients ranging from 4-6 gram/dl and 4 
patients had protein levels above 6 gram/dl. 
Table 8. Distribution of pleural cholesterol
 
15 patients had pleural cholesterol levels less than 45 
mg/dl and 45 patients had cholesterol level above 45 
mg/dl. 
Table 9. Biochemical analysis of pleural effusion
 
Note: * significant at 5% level of significance (p<0.05). 
The p value of serum protein is 0.215, 
According to Lights Criteria, the mean serum protein is 
5.7±1.0 in exudates and 6.1±1.1 has p value of 0.215. 
The mean pleural protein is 4.7±1.0 in exudates and 
2.4±0.9 has p value of 0.001. The mean pleural sugar is 
68.2±40.1 in exudates and 126.7±75.9 has p value of 
0.001. The mean pleural protein: serum protein is 
Pleural protein (gram/dl) Number (n=60) 
1-2 6 
2-4 16 
4-6 34 
>6 4 
Total 60 
Pleural cholesterol N 
<45 mg/dl 15 
>45 mg/dl 45 
Total 60 
Parame-
ters (g/dl) 
Exudates 
Transu-
date 
P VALUE 
  
Mean ± 
SD 
Mean±SD   
Lights criteria (transudate=14 exudate=46) 
Serum 
protein(g/
dl) 
5.7±1 6.1±1.1 0.215 
Pleural 
protein(g/
dl) 
4.7±1 2.4±0.9 <0.001* 
Pleural 
sugar(mg/
dl) 
68.2±40.1 126.7±76 <0.001* 
Pleural 
fluid pro-
tein:Serum 
protein 
0.8±0.2 0.3±0.1 <0.001* 
Pleural cholesterol criteria(transudate=15  exu-
date=45) 
Pleural 
cholesterol
(mg/dl) 
78.2±23.7 21.9±9.2 <0.001* 
0.8±0.2 in exudates and 0.3± 0.1 has p value of 0.001. 
According to pleural cholesterol criteria, the mean pleu-
ral cholesterol is 78.2±23.7 in exudates and 21.9±9.2 
and has p value of 0.001 which is statistically signifi-
cant. 
pleural protein is <0.001, pleural sugar is <0.001, pleu-
ral cholesterol is <0.001, pleural fluid protein: serum 
protein is <0.001. P value of <0.001 is statistically sig-
nificant.  
Table 10.  Distribution of exudates and transudate 
according to lights criteria and pleural fluid choles-
terol criteria3 
 
Based on Lights criteria, out of 60 patients 46 were exu-
dates (76.7%) and 14 were transudates (23.3%).Based 
on pleural cholesterol level criteria, out of 60 patients 45
(75%) were exudates and 15(25%) were transudates. 
Table 11. Result of sputum AFB
 
In the study group of 60 patients, sputum AFB was pos-
itive in 32 (53.3%) patients and 28 (53.3%) patients had 
sputum AFB was negative. 
Table 12. USG abdomen examination in pleural effu-
sion
 
In the study group of 60 patients, cirrhosis was present 
in 7 patients, hepatomegaly in 1 patient, ascites in 1 
patient, and normal in 39 patients. 
Based on lights criteria N % 
Exudate 46 76.7 
Transudate 14 23.3 
Based on cholesterol criteria 
Exudate 45 75 
Transudate 15 25 
Sputum AFB 
TOTAL 
P VALUE 
N % 
Negative 28 46.7 
0.232 Positive 32 53.3 
Total 60 100.0 
USG 
Total 
p value 
N % 
Cirrhosis with por-
tal hypertension 
7 11.7 
0.182 
Mild hepatomegaly 1 1.7 
Minimal ascites 1 1.7 
Normal 39 65.0 
Not done 12 20.0 
Total 60 100.0 
Mulimani et al.  Differentiating transudative and exudative pleural effusion by pleural fluid cholesterol. 
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Table 13. Comparison of exudative and transudative 
pleural effusion according to pleural fluid cholesterol 
criteria and lights criteria
 
Note: * significant at 5% level of significance (p<0.05) 
Based on lights criteria 46 patients were exudate and 14 
patients were transudative pleural effusion, based on 
cholesterol criteria 45 patients were exudative and 15 
were transudative pleural effusion.  
The p value is < 0.001 which is statistically significant. 
Table 14. Sensitivity analysis of pleural cholesterol 
criteria
 
DISCUSSION 
A total of 60 patients were taken up for this study. Out 
of 60, 46 were exudates and 14 were transudates. 
Among 46 exudates, 40 were tubercular effusions, 5 
patients were synpneumonic effusion and 1 patient with 
malignant effusion. 
Among 14 transudative, 7 patients were congestive car-
diac failure, 7 patients were cirrhosis. 
Age and sex: The age of the patient in this study ranged 
from 18 years to 75 years. 1 patient was 18 years, 9 pa-
tients were between 21-30 years, 15 patients were be-
tween 31-40 years, 15 patients were between 41-50 
years, 13 patients were between 51-60 years and 7 pa-
tients were above 60 years. Out of 60 patients, males 
were 38 and females were 22.  
Hamm4 first used pleural cholesterol as a parameter. In 
his study of 150 patients he found excellent results 
(Sensitivity 93%, Specificity 100%, Accuracy 96%). 
Following Hamm’s [4], Valdes [5] aimed to validate 
this parameter. In his study of 74 patients pleural cho-
lesterol had good results as shown in the above table. 
Similar results were obtained from studies by Ram [6] 
in 100 patients and B N Mohaptra [7] in his study of 132 
patients. The studies of Burgess [8] and Remero [9] of 
124 patients, results were in favour of lights criteria but 
  
According to 
pleural fluid 
cholesterol  
criteria 
According 
to lights 
criteria 
  
P value 
  N (%) N(%)   
Exudate 45 (75) 46 (76.6) 
  
<0.001* 
Transu-
date 
15(25) 14 (23.3) 
Total 60 60 
TP (true positive) 45 
FN (false negative) 1 
FP (false positive) 0 
TN (true negative) 14 
Sensitivity 97.8% 
Specificity 100.0% 
PPV(positive predictive value) 100.0% 
NPV(negative predictive value) 93.3% 
Accuracy 98.3% 
they had less sensitivity, specificity and accuracy. As a 
result the present study of 60 patients which contains 
Pleural Cholesterol criteria has more sensitivity, speci-
ficity and accuracy when compared to other studies 
done by Burgess and Remero which contains Lights 
criteria. 
The study shows that pleural fluid cholesterol criteria 
(cholesterol >45 mg/dl - exudate and cholesterol <45 
mg/dl – transudate) constitute a useful tool for the sepa-
ration of pleural effusions. 
CONCLUSION 
The pleural fluid cholesterol criteria were found to be 
the most efficient criteria. Since this parameter involves 
the measurement of only pleural fluid values of choles-
terol, it has following advantages: Economically, it re-
duces number of biochemical tests, Simpler, as there is 
no need to take simultaneous blood sample at the time 
of thoracocentesis. 
It is concluded that the determination of pleural fluid 
cholesterol criteria can be included in routine analysis of 
pleural fluid samples in place of presently used Lights 
Criteria. 
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